Blossom is a research and intelligence platform for psychedelics as medicine. We help professionals keep up with a fast-moving field by connecting scientific evidence, clinical development, and real-world ecosystem signals in one place.

Our database brings together research papers, clinical trials, compounds, indications, sponsors, and key organisations, with structured metadata and links across the full landscape. This makes it easier to move from a single result to the broader context: What else has been studied in this indication? Which endpoints were used? What dose and protocol? Who is funding the work? What is in Phase I, Phase II, and Phase III? What is publishing now, and what is coming next?

Blossom is used by operators and decision-makers who need clarity without hype: clinicians and service builders, biotech and pharma teams, policy and payer stakeholders, investors, and researchers. We prioritise accuracy, traceability to sources, and practical synthesis that supports decisions on development strategy, implementation, and access.

Subscribe to the Blossom newsletter for a weekly briefing on new studies, trial updates, policy and market developments, and original analysis.

Blossom

Org chart

Teams

Offices